Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots. The company is headquartered in Shanghai, Shanghai and currently employs 440 full-time employees. The company went IPO on 2021-11-02. The Company’s main business is engaged in the research and development, manufacturing and sale of surgical robots. The Company’s products include Toumai Laparoscopic Surgical Robot, Skywalker Orthopedic Surgical Robot, R-one vascular intervention surgical robot, Microport Medbot and other products, covering surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The firm conducts its business in the domestic and overseas markets.
Follow-Up Questions
SMMBF 주식의 가격 성능은 어떻습니까?
SMMBF의 현재 가격은 $1.68이며, 전 거래일에 decreased 0% 하였습니다.
Shanghai MicroPort MedBot Group Co Ltd의 주요 사업 주제나 업종은 무엇입니까?
Shanghai MicroPort MedBot Group Co Ltd은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Shanghai MicroPort MedBot Group Co Ltd의 시가총액은 얼마입니까?
Shanghai MicroPort MedBot Group Co Ltd의 현재 시가총액은 $NaN입니다
Shanghai MicroPort MedBot Group Co Ltd는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 7명의 분석가가 Shanghai MicroPort MedBot Group Co Ltd에 대한 분석 평가를 실시했으며, 이는 4명의 강력한 매수, 4명의 매수, 3명의 보유, 0명의 매도, 그리고 4명의 강력한 매도를 포함합니다
